Neuropsychiatric Syndromes PIA: Response Variability to Methylphenidate in AD

February 5, 2025

Dr. Krista Lanctôt presents findings from the ADMET 2 Trial, exploring variability in methylphenidate response for apathy in Alzheimer’s disease and its implications for managing neuropsychiatric symptoms.
Moderator: Daniella Vellone
Speaker: Krista Lanctôt